Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Interventional × Prebiotics × Clear all

Phase

Phase NA 3 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Anus Neoplasms 1

Interventions

Cisplatin 1329 Carboplatin 1246 Cyclophosphamide 1186 Bevacizumab 1085 Gemcitabine 1081 Paclitaxel 1063 Radiotherapy 1046 Docetaxel 971 pembrolizumab 904 Oxaliplatin 818 Capecitabine 802 Fluorouracil 753 Rituximab 654 Doxorubicin 594 Nivolumab 588 Dexamethasone 587 Etoposide 584 Irinotecan 562 Leucovorin 519 Pemetrexed 443 Drug Therapy 422 Cetuximab 416 Cytarabine 409 Trastuzumab 406 Magnetic Resonance Spectroscopy 395 Filgrastim 390 Prednisone 377 Lenalidomide 354 Bortezomib 354 Temozolomide 349

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03870607 2023-01-17

BISQUIT

AC Camargo Cancer Center

Phase 2 Unknown

Gastrointestinal

Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡